U.S. Flu Rates Remain Low as Experts Watch New Strain Linked to Early Global Outbreaks
U.S. flu activity stays low, but a new H3N2 strain linked to…
FDA Approves Revolutionary mRNA Flu Vaccine with 90% Efficacy in Late-Stage Trials
FDA grants emergency approval to Moderna's mRNA flu vaccine with 90% efficacy…
FDA Approves Revolutionary mRNA Flu Vaccine with 95% Efficacy Against Dominant H3N2 Strain
FDA approves mRNA flu vaccine with 95% efficacy vs. H3N2 strain amid…
